CD274 and non-small cell lung carcinoma: This article focuses on PD-1/PD-L1 NSCLC immunotherapy, discussing sex differences in response to PD-L1 blockade, as well as sex-related effects and sex hormones impact on the PD-1/PD-L1 pathway and therapeutic responses implications.